2022-07-05-世界卫生组织-Immunization_Belgium_2022_country_profile_26页_357kb
报告摘要
Belgium Immunization Coverage Summary (WHO & UNICEF, 2021 Revision, July 8, 2022)
- BCG Vaccine: No estimates available for 2010-2021.
- DTP1 (Diphtheria/Tetanus/Pertussis): Coverage consistently high (98-99%), stable or slight decreases noted in some years (e.g., 99% in 2020-2021), supported by surveys and government data with GoC R+.
- DTP3 (Third Dose): Coverage around 97-98%, minor fluctuations (e.g., 99% in 2016-2019, 97% in 2021), based on surveys and stable coverage assumptions, GoC R+.
- Pol3 (Third Dose of Polio): Coverage high and stable (e.g., >98%), reflecting routine immunization performance, GoC R+.
- IPV1 (Inactivated Polio): Coverage estimates available from 2015 onward (~99%), introduced to mitigate polio risks, GoC R+.
- MCV1 (Measles First Dose): Coverage around 95-96%, stable or slight variations, based on surveys and government data, GoC R+.
- MCV2 (Measles Second Dose): Coverage extrapolated or based on assumptions in some years (e.g., 83-85% range), with GoC No accepted empirical data in 2021.
- RCV1 (Rubella First Dose): Coverage estimated based on MCV1, around 95-96%, GoC R+.
- HepB3 (Hepatitis B Third Dose): Coverage stable around 97%, based on surveys and government data, GoC R+.
- Hib3 (Haemophilus influenzae Type b Third Dose): Coverage around 96-98%, stable with slight variations, GoC R+.
- RotaC (Rotavirus): Coverage varies (e.g., ~80-90%), lower than other vaccines, based on surveys, GoC R+.
- PcV3 (Pneumococcal Conjugate Third Dose): Coverage around 90-95%, stable with minor fluctuations, GoC R+.
- Methodology: Estimates rely on empirical data (e.g., surveys, administrative reports), with no adjustments from other countries. A grade of confidence (GoC) indicates data support level, but no confidence intervals provided. Estimates should be used cautiously due to potential data biases or gaps.
- Survey Details: Data from Flanders, Wallonia, and Brussels regions based on regional surveys (e.g., 2010-2021), with population-weighted samples and card checks confirming coverage.
- Trends: Immunization coverage has been high and relatively stable for most vaccines, with minor decreases in some doses but no significant dips in overall key indicators. Rotavirus coverage remains lower.
展开完整摘要
试读结束,高清完整版pdf/doc/ppt,请点下载